[Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
出版信息
MMW Fortschr Med. 2003 Dec 18;145(51-52):41.
PMID:14974333
Abstract
摘要
相似文献
1
[Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].外周动脉闭塞性疾病中的微循环将会改善。前列腺素可预防手术。
MMW Fortschr Med. 2003 Dec 18;145(51-52):41.
2
Peripheral arterial disease: drug therapy.
J Gend Specif Med. 2002 Jul-Aug;5(4):16-20.
3
A randomized trial of iloprost in patients with intermittent claudication.伊洛前列素治疗间歇性跛行患者的随机试验。
Vasc Med. 2008 Feb;13(1):5-13. doi: 10.1177/1358863X07084910.
4
[Treatment of peripheral arterial diseases].
Orv Hetil. 2005 May 29;146(22):1209-11.
5
The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.伊洛前列素对间歇性跛行患者血液流变学及组织灌注的影响
Kardiol Pol. 2003 Sep;59(9):197-204.
6
[Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
Hamostaseologie. 2006 Aug;26(3):220-3.
7
Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options.外周动脉供血不足：机制、自然病史及治疗选择。
Adv Intern Med. 1998;43:253-77.
8
[Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
Clin Ter. 1985 Jul 15;114(1):3-26.
9
[Shunt effect in iloprost treatment of obliterative arteriopathy].
Minerva Cardioangiol. 1999 Dec;47(12):654-5.
10
[Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
Z Gesamte Inn Med. 1991 Mar;46(3):59-67.
Zotero 插件